Idea Cellular Bevétel Q/Q
Mi az Idea Cellular Bevétel Q/Q?
A Bevétel Q/Q az Idea Cellular Limited - -5.41%
Mi a Bevétel Q/Q meghatározása?
A negyedéves árbevétel-növekedés évről évre meghaladja a társaság bevételeinek növekedését az előző év azonos negyedévének százalékos arányában kifejezett teljesítményéhez képest.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Bevétel Q/Q a Communication Services szektor a BSE-on cégekben a Idea Cellular -hoz képest
Mit csinál Idea Cellular?
Vodafone Idea Limited operates mobile telecommunications in India. The company offers 2G, 3G, and 4G services; prepaid, postpaid, and roaming services, as well as interconnect and long distance services; voice, data, and enterprise services, as well as various other value added services, including short messaging services, digital services, Internet of Things, etc. It also trades in handsets, data cards, and related accessories; and provides internet, mobile advertisement, toll free services, etc. Vodafone Idea Limited has approximately 293.7 million mobile subscribers. The company was formerly known as Idea Cellular Limited and changed its name to Vodafone Idea Limited in August 2018. Vodafone Idea Limited was incorporated in 1995 and is based in Mumbai, India.
bevétel q/q -hoz hasonló cégek Idea Cellular
- Encavis AG nak Bevétel Q/Q -5.44% van
- Putnam Municipal Opportunities Trust nak Bevétel Q/Q -5.43% van
- Gates Industrial plc nak Bevétel Q/Q -5.43% van
- Arvind SmartSpaces nak Bevétel Q/Q -5.43% van
- Petrofac nak Bevétel Q/Q -5.43% van
- Pfizer nak Bevétel Q/Q -5.42% van
- Idea Cellular nak Bevétel Q/Q -5.41% van
- Ober SA nak Bevétel Q/Q -5.40% van
- Zimplats nak Bevétel Q/Q -5.38% van
- Hamborner REIT AG nak Bevétel Q/Q -5.38% van
- AstraZeneca Pharma India nak Bevétel Q/Q -5.37% van
- Anika Therapeutics nak Bevétel Q/Q -5.37% van
- Pimco Income Strategy Fund II nak Bevétel Q/Q -5.37% van